365 related articles for article (PubMed ID: 6939876)
1. The side effects of penicillamine therapy in rheumatoid arthritis.
Huskisson EC
J Rheumatol Suppl; 1981; 7():146-8. PubMed ID: 6939876
[TBL] [Abstract][Full Text] [Related]
2. Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine.
Stockman A; Zilko PJ; Major GA; Tait BD; Property DN; Mathews JD; Hannah MC; McCluskey J; Muirden KD
J Rheumatol; 1986 Apr; 13(2):269-73. PubMed ID: 3459889
[TBL] [Abstract][Full Text] [Related]
3. [Early recognition of adverse effects, especially of kidney lesions, in patients with progressive chronic polyarthritis under D-Penicillamine therapy].
Otto W; Pietruschka WD; Beenken O
Z Gesamte Inn Med; 1975 Aug; 30(15):507-9. PubMed ID: 1189496
[TBL] [Abstract][Full Text] [Related]
4. Longterm followup of treatment with D-penicillamine for rheumatoid arthritis: effectivity and toxicity in relation to HLA antigens.
Moens HJ; Ament BJ; Feltkamp BW; van der Korst JK
J Rheumatol; 1987 Dec; 14(6):1115-9. PubMed ID: 3437418
[TBL] [Abstract][Full Text] [Related]
5. Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group.
J Rheumatol; 1987 Feb; 14(1):67-73. PubMed ID: 2952797
[TBL] [Abstract][Full Text] [Related]
6. [The basal therapy of rheumatoid arthritis with d-penicillamine (author's transl)].
Waskönig FW; Meyer W
Munch Med Wochenschr; 1973 Nov; 115(45):2047-50. PubMed ID: 4801138
[No Abstract] [Full Text] [Related]
7. C1 inhibitor deficiency in a patient with rheumatoid arthritis--increased risk of adverse effects of penicillamine?
Sturfelt G; Rydgren L; Truedsson L; Alm P; Sjöholm AG
J Rheumatol; 1996 Feb; 23(2):378-81. PubMed ID: 8882051
[TBL] [Abstract][Full Text] [Related]
8. [Current status of D-penicillamine therapy in chronic polyarthritis].
Franke M; Menning H; Ströbel G
Z Rheumatol; 1981; 40(2):54-61. PubMed ID: 7282106
[TBL] [Abstract][Full Text] [Related]
9. Lack of induction of antinuclear antibodies by D-penicillamine in rheumatoid arthritis: a controlled study.
Weinstein A; Rothfield NF
J Rheumatol; 1986 Apr; 13(2):308-12. PubMed ID: 3487646
[TBL] [Abstract][Full Text] [Related]
10. An assessment of penicillamine therapy in rheumatoid arthritis and the influence of previous gold therapy.
Webley M; Coomes EN
J Rheumatol; 1979; 6(1):20-4. PubMed ID: 439106
[TBL] [Abstract][Full Text] [Related]
11. Penicillamine treatment of rheumatoid arthritis: relationship of proteinuria and autoantibodies to immune status.
Zilko PJ; Dawkins RL; Cohen ML
Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):118-22. PubMed ID: 122657
[TBL] [Abstract][Full Text] [Related]
12. Penicillamine induced lupus-like syndrome in a patient with classical rheumatoid arthritis.
Chin GL; Kong NC; Lee BC; Rose IM
J Rheumatol; 1991 Jun; 18(6):947-8. PubMed ID: 1895285
[No Abstract] [Full Text] [Related]
13. Penicillamine in rheumatoid disease: a long-term study.
Day AT; Golding JR; Lee PN; Butterworth AD
Br Med J; 1974 Feb; 1(5900):180-3. PubMed ID: 4590670
[TBL] [Abstract][Full Text] [Related]
14. Intermittent treatment with D-penicillamine is effective in lower doses and with fewer adverse effects in patients with rheumatoid arthritis.
Hakoda M; Taniguchi A; Kamatani N; Akahoshi T; Kashiwazaki S
J Rheumatol; 1994 Sep; 21(9):1637-41. PubMed ID: 7799341
[TBL] [Abstract][Full Text] [Related]
15. [A case report of rheumatoid arthritis which showed acute renal failure, nephrotic syndrome and drug-related lupus-like syndrome caused by D-penicillamine].
Suda M; Yoshikawa Y; Suzuki T; Dohi Y; Shibata T
Nihon Jinzo Gakkai Shi; 1990 Nov; 32(11):1235-41. PubMed ID: 2082056
[TBL] [Abstract][Full Text] [Related]
16. The relationship between D-penicillamine--induced proteinuria and prior gold nephropathy.
Billingsley LM; Stevens MB
Johns Hopkins Med J; 1981 Feb; 148(2):64-7. PubMed ID: 7206401
[TBL] [Abstract][Full Text] [Related]
17. Multiple side effects of penicillamine therapy in one patient with rheumatoid arthritis.
Essigman WK
Ann Rheum Dis; 1982 Dec; 41(6):617-20. PubMed ID: 6216862
[TBL] [Abstract][Full Text] [Related]
18. [Cutaneous side effects induced by D-penicillamine in the treatment of rheumatoid arthritis].
Broggini M; Baratelli E; Cappelli A; Crespi E; Filardi PG; Volontè S
Minerva Med; 1990 Mar; 81(3):197-201. PubMed ID: 2138721
[TBL] [Abstract][Full Text] [Related]
19. Penicillamine in the treatment of rheumatoid arthritis.
Camp AV
J Rheumatol Suppl; 1981; 7():103-6. PubMed ID: 6939871
[TBL] [Abstract][Full Text] [Related]
20. [D-penicillamine--side effects, pathogenesis and decreasing the risks].
Grasedyck K
Z Rheumatol; 1988; 47 Suppl 1():17-9. PubMed ID: 3063003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
